VI International sCIENTIFIC AND PRACTICAL CONFERENCE

“HEALTH TECHNOLOGY ASSESSMENT: iNNOVATIONS IN THE nATIONAL HEALTH CARE SYSTEM. personalized medicIne”

organizers:

Federation Council Committee on Social Policy

Ministry of Health of the Russian Federation

Ministry of Finance of the Russian Federation

Federal Compulsory Medical Insurance Fund

Federal Service for Surveillance in Healthcare

Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

Financial Research Institute of the Ministry of Finance of the Russian Federation

Scientific and Clinical Center of Otorhinolaryngology of the Federal Medico-Biological Agency of the Russian Federation

Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

National Center for Health Technology Assessment

Health Technology Assessment Association

Biomedical Cell Products Manufacturers’ Association

Russia HTA Chapter of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

 

Renaissance Moscow Monarch Centre Hotel

Moscow, October 8, 2019

PROGRAM

9:00-       10:00

REGISTRATION

ANDREEVSKIY HALL

  10:00 - 10:30

 

WELCOME MESSAGE

 

Igor Kagramanyan – First Deputy Chair of the Federation Council Committee on Social Policy;

Igor Korobko – Director of the Department of Science, Innovative Development and Management of Biomedical Health Risk at the Ministry of Health of the Russian Federation;

Alexey Alekhin – Head of the Department of Pharmaceutical and Medical Industry Development;

Svetlana Gashkina - Director of the Department of Budget Policy in the Social Sphere and Science of the Russian Federation;

Mikhail Murashko - Chief of the Federal Service for Surveillance in Healthcare;

Olga Tsareva – Head of the Department for the Modernization of the Compulsory Medical Insurance System of the Federal Compulsory Medical Insurance Fund;

Nikolay Daikhes – Director of the Scientific and Clinical Center of Otorhinolaryngology of the Federal Medico-Biological Agency of the Russian Federation, Member of the Civic Chamber of the Russian Federation;

Vitaly Omelyanovskiy - General Director of the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

 

 

 

 

 

 

 

 

 

 

 

 

 

10:30 -12:10

 

 

 

 

1. Cell and gene therapy. Clinical aspects

1.    Prospects of biomedical cell products circulation in the Russian Federation - Igor Korobko– Director of the Department of Science, Innovative Development and Biomedical Health Risk Management of the Ministry of Health;

2.    Pipeline review of innovative therapies - Stefan Vranckx – Chief of the International Department of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussel, Belgium;

3.    International experience overview of applying gene therapy - Francesco Testa – MD, PhD, IRD specialist, Associate Professor of Ophthalmology, School of Medicine, University of Campania Luigi Vanvitelli, Naples, Italy;

4.     Bringing advanced therapy medicinal products (ATMP) to clinical delivery in the NHS public healthcare system - Antonio Pagliuca - MB BS, MA, FRCP, FRCPath, Medical Director for Networked Care/Specialist Services, Clinical Director for Private Patient Services, Professor of Stem Cell Transplantation, Consultant Haematologist/Honorary Senior Lecturer, London, UK;

5.    Cell technologies in optimizing the results of hematopoietic cell transplantation in children (clinical testing role)- Galina Novichkova – General Director, Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology;

6.    First experience of CAR-T cell therapy for cancer treatment in Russia: results and prospects - Mikhail Maschan - MD, PhD, DSc, Professor, Deputy General Director of the Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology; Director of the High School of Molecular and Experimental Medicine;

12:10 – 12:30

Coffee break

12:30 – 13:20

2. Cell and gene therapy. Implementation

 

1.    Gene and cell therapies: international experience of assessment and reimbursement- Josie Godfrey - Director, JG Zebra Consulting, London, UK;

2.    Innovative models of medicine provision - Timofey Nizhegorodtsev - Head, Department for Control over Social Sphere and Commerce, Federal Anti-Monopoly Service;

3.    Challenges for ATMP development in Russia - Roman Ivanov – MD, PhD, Vice-President, Research and Development (BIOCAD);

1.    4. Biomedical cell products: development of a new pharmaceutical industry segment - Alexey Martynov – President of Biomedical Cell Products Manufacturer’s Association;                  

13:20 – 14:00

Questions & Discussion

14:00 – 15:00

LUNCH

15:00 – 16:30

3. Personalized medicine and companion diagnostics.

1. Evolution of molecular testing: Role of comprehensive genomic profiling in Precision Medicine - Bahadir Pekin – MD, International Scientific Lead, Foundation Medicine, Switzerland;

2. Molecular-genetic and histochemical studies of cancer patients in the Russian Federation – current status and prospects -Sergey Tyulyandin - MD, PhD, DSc, Professor, Deputy Director, Head of the Clinical Pharmacology and Chemotherapy Department, N. N. Blokhin Medical Research Center of Oncology

3. Precision medicine & Comprehensive Genomic Profiling: Exploring the clinical and economic impact - Teresa García Coscolín - Access Lead, Pharma International, Foundation Medicine, Switzerland;

4. Experience in evaluating NGS medical services in healthcare systems in the European Union - Maarten Kempen - Clinical Sales Director Reproductive & Genetic Health Europe, Middle East & Africa for Illumina, The Netherlands;

5. Prospects of new generation sequencing (NGS) implementation in the Russian Federation - Evgeniy Imyanitov – MD, PhD, DSc, Professor Head of the Biology of Tumor Growth Department, N. N. Petrov National Medical Research Oncology Center;

6. The problem of the genetic testing reliability in the Russian Federation - Boris Gorodetskiy – General Director of “Kod Zdorovia”;

7. Diagnostic tests: How to evaluate their adaptability to the system- Vitaliy Omelyanovskiy – General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation.

16:30 - 17:00

CONCLUSION



APPLY FOR REGISTRATION

Registration period has passed